Bizarre Patents
A banana protective device for storing and transporting a banana carefully.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8187617 | Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments. ... | 05/29/2012 |
| 8187616 | Method for silk fibroin gelation using sonication This invention provides for a process of rapidly forming silk fibroin gelation through ultrasonication. Under the appropriate conditions, gelation can be controlled to occur within two hours after the ultrasonication treatment. Biological materials, including viable... | 05/29/2012 |
| 8187615 | Non-aqueous compositions for oral delivery of insoluble bioactive agents The present invention provides a composition of low water solubility drug, dissolved or dispersed in a non crystalline or low crystalline form in an emulsion type composition of internal oily-solvent and external non-hydrous and water soluble solvent, whereas 1) emu... | 05/29/2012 |
| 8182824 | Ciclesonide-containing sterile aqueous suspension The present invention provides a ciclesonide-containing sterile aqueous suspension sterilized by autoclaving, wherein the concentration of ciclesonide after autoclaving is 95% or more compared to that before autoclaving. ... | 05/22/2012 |
| 8182825 | Message energy memory ceramics The present invention provides a message energy memory ceramics. The message information memory ceramics includes: (1) a plurality of message energy memory ceramics grains composed of a silicon oxide, an aluminum oxide, a sodium oxide, a potassium oxide, a magnesium... | 05/22/2012 |
| 8178112 | Ketoprofen compositions and methods of making them A wide variety of pharmaceutically and commercially acceptable dosage forms of ketoprofen are prepared by dissolving ketoprofen in pharmaceutically acceptable solvents. ... | 05/15/2012 |
| 8173142 | Pharmaceutical compositions of drugs and neutralized acidic polymers Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed. ... | 05/08/2012 |
| 8168209 | Method and composition for administering an NMDA receptor antagonist to a subject The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject. ... | 05/01/2012 |
| 8168208 | Silica-calcium phosphate bioactive composite for improved synthetic graft resorbability and tissue regeneration A method is disclosed for the generation of bone tissue by the preparation and the application to bone defect sites of a resorbable silica-calcium phosphate bioactive composite (SCPC) that finds utility as a bone tissue engineering scaffold. The resorbable silica-ca... | 05/01/2012 |
| 8163298 | Aqueous gel having an alpha-hydroxy acid and suspended particulates A personal care composition in the form of an aqueous gel may comprise an alpha-hydroxy acid, wherein the pH of the composition is less than about 4.5. The personal care composition comprises a gelling agent and an aqueous solvent. The personal care composition furt... | 04/24/2012 |
| 8163299 | Stabilized pharmaceutical product Use of an adsorbent and a sealed package (e.g. an overwrap) to protect a pharmaceutical product in a solid state in the presence of a reducing sugar. ... | 04/24/2012 |
| 8158135 | Imine based liquid crystals for the controlled release of bioactive materials The present invention relates to a delivery system based on a film of an imine forming liquid crystalline phase, mixed with at least with one biologically active substance, to which a constant or variable electric field can be applied. The delivery system can be use... | 04/17/2012 |
| 8158134 | Microemulsion preconcentrate, microemulsion and use thereof The invention relates to compositions in the form of microemulsion preconcentrates that contain (a) a mixture that consists of a medium-chain triglyceride and an omega-9 fatty acid and/or an omega-6 fatty acid; and (b) a surface-active component that contains a poly... | 04/17/2012 |
| 8153142 | Skin treatment composition A skin treatment composition of the present invention is an external composition for skin comprising an alkylene oxide derivative expressed by Formula (I): R1O-[(AO)m(EO)n]—R2 (I) wherein AO is a... | 04/10/2012 |
| 8147851 | Treating eczema and/or psoriasis The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate. ... | 04/03/2012 |
| 8147852 | Modified azole compounds as antifungal and antibacterial agents The present invention relates to the compounds of formula (I), their preparation and use as antifungal and/or antibacterial agents. where the values for R1, R2, R3, R4, R5 | 04/03/2012 |
| 8142800 | Oral high potency clinical anti-craving treatment and method of use A practical high potency anti-craving oral medication or combined oral/IV drip medication is disclosed which comprises three components: a group of amino-acid substances, a group of vitamin substances, and a group of minerals, wherein each substance is selected for ... | 03/27/2012 |
| 8142799 | High potency clinical anti-craving treatment and method of use A practical high potency anti-craving medication is disclosed which comprises three components: an amino-acid component, a vitamin component, and a mineral component, wherein each component is selected for maximum efficacy in the body of an individual suffering from... | 03/27/2012 |
| 8137683 | Process for the preparation of dispersions The present invention relates to a process of a dispersion of an active substance or composition in a aqueous phase which comprises dispersing in an aqueous phase a solution of such substance or composition in dimethylether or in a C4-hydrocarbon or mixtures thereof... | 03/20/2012 |
| 8137684 | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof In accordance with the present invention, there are provided compositions and methods useful for the in vivo delivery of substantially water insoluble pharmacologically active agents (such as the anticancer drug paclitaxel) in which the pharmacologically active agen... | 03/20/2012 |
| 8128945 | Drug delivery system targeting to estrogen receptor over-expressed cells A vector for targeted delivery of drugs into estrogen receptors over-expressed cells is disclosed. The vector of the present invention is mainly about an active targeting delivery carrier which consists of a plurality of nanoparticles including: (i) a plurality of t... | 03/06/2012 |
| 8128946 | Medical tape preparation A medical tape preparation which comprises a support and, superposed on one side thereof in the following order, a pressure-sensitive adhesive layer and a release liner. The pressure-sensitive adhesive layer can contain a large amount of an oleophilic oily matter. T... | 03/06/2012 |
| 8114420 | Composition for treating dry eye and related methods of manufacture and methods of use The present invention is directed to a composition for treating dry eye comprising, in one embodiment, carboxymethylcellulose and a polyol. Such compositions have been found to alleviate the symptoms of dry eye and remain in the eye for a long period of time. ... | 02/14/2012 |
| 8114421 | Coated products containing hydrogenated indigestible starch syrup as a binding agent An object of the present invention is to provide a coated product with increased stiffness to reduce the chipping after manufacturing and several days of storage, and before wrapping. A coated product such as confectioneries such as chewing gum, medicines and medici... | 02/14/2012 |
| 8110205 | Silver-containing inorganic antibacterial The present invention is completed by finding that a silver ion-containing zirconium phosphate represented by the following formula (1) is excellent in heat resistance and chemical resistance, low in resin coloring and excellent in processability. Aga... | 02/07/2012 |
| 8097263 | Silver-containing inorganic antibacterial The present invention provides a silver based inorganic antibacterial agent excellent in heat resistance and chemical resistance, lowered in resin coloring and excellent in processability. The present invention has been completed by finding out that problems can be ... | 01/17/2012 |
| 8097262 | Gel type enteral nutrient An enteral nutrient gel that is excellent at maintaining its solid matter (gel) form in the stomach, does not readily disintegrate or dissolve with a change in pH, is stable in its physical properties even during long-term storage, and can be passed through a feedin... | 01/17/2012 |
| 8088398 | Pharmaceutical compositions comprising fesoterodine The present application relates to a pharmaceutical granulate comprising Fesoterodine or a pharmaceutically acceptable salt or solvate thereof and a pharmaceutically acceptable stabilizer, which can be selected from the group consisting of sorbitol, xylitol, polydex... | 01/03/2012 |
| 8084048 | Vascularization enhanced graft constructs A tissue graft construct for use in repairing diseased or damaged tissues is provided. The tissue graft construct comprises a matrix composition selected from the group consisting of liver basement membrane and extracts and hydrolysates thereof, and processed collag... | 12/27/2011 |
| 8084047 | Compositions and methods for treatment of eye disorders The present invention provides compounds and methods for the treatment of LFA-1 mediated diseases. In particular, LFA-1 antagonists are described herein and these antagonists are used in the treatment of LFA-1 mediated diseases. One aspect of the invention provides ... | 12/27/2011 |
| 8084046 | Inhibition of exoprotein production in absorbent articles using isoprenoids Absorbent articles, such as catamenial tampons, are disclosed. The absorbent articles include an effective amount of an isoprenoid inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria. The isoprenoid inhibitory compounds... | 12/27/2011 |
| 8071114 | Compositions containing quaternary ammonium compounds This invention relates to compositions containing quaternary ammonium compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, characterized in that said composition includes at least 20% in weight by weight of... | 12/06/2011 |
| 8067017 | Preservation of bioactive materials by freeze dried foam This invention provides methods and compositions to preserve bioactive materials in a dried foam matrix. Methods provide non-boiling foam generation and penetration of preservative agents at temperatures near the phase transition temperature of the membranes. ... | 11/29/2011 |
| 8062647 | High concentration baclofen preparations Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of pre... | 11/22/2011 |
| 8057811 | Stable clozapine suspension formulation A physicochemically stable aqueous composition including clozapine suspension. ... | 11/15/2011 |
| 8052982 | Bioimplant formulation comprising lecithin and stearin Pharmaceutical and/or veterinary formulation containing about 2-30% (w/w) (on an active basis) of at least one active agent, about 0.5-20.0% (w/w) of a pore-forming agent comprising lecithin and an organic salt, and the balance stearin. ... | 11/08/2011 |
| 8039009 | Modified release formulations of memantine oral dosage forms The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptab... | 10/18/2011 |
| 8039010 | Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier A biocompatible, sustained release intraocular drug delivery system comprising a protein or polynucleotide therapeutic agent, a polymeric carrier for the therapeutic agent and a long chain fatty alcohol release modifier. The biocompatible, sustained release intraocu... | 10/18/2011 |
| 8029810 | Water-based delivery systems The invention relates to a water-based delivery system for an active substance, characterized by enhancing skin barrier restoration in the stratum corneum comprising water, a fatty acid, cholesterol, a ceramide and at least one skin lipid precursor. ... | 10/04/2011 |
| 8029811 | Stabilized pharmaceutical product Use of an adsorbent and a sealed package (e.g. an overwrap) to protect a pharmaceutical product in a solid state in the presence of a reducing sugar. ... | 10/04/2011 |
